These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6364600)

  • 1. [Clinical principles of bone marrow transplantation].
    Niethammer D
    Verh Dtsch Ges Pathol; 1983; 67():318-27. PubMed ID: 6364600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone marrow transplantation in malignant proliferative hematologic diseases].
    Adamczyk MB; Rupniewska ZM
    Pol Tyg Lek; 1984 Feb; 39(7):229-32. PubMed ID: 6379621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical bone marrow transplantation--indications and results].
    Heimpel H
    Verh Dtsch Ges Inn Med; 1987; 93():75-82. PubMed ID: 3327304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Totality of nursing care for patients undergoing bone marrow transplantation].
    Bourbonnais F; Bédard J
    Infirm Can; 1983 Feb; 25(2):29-34. PubMed ID: 6341254
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indication of bone marrow transplantation].
    Masaoka T
    Rinsho Byori; 1995 Jul; Suppl 99():1-7. PubMed ID: 7474413
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease.
    Kanda Y; Tanaka Y; Shirakawa K; Yatomi T; Nakamura N; Kami M; Saito T; Izutsu K; Asai T; Yuji K; Ogawa S; Honda H; Mitani K; Chiba S; Yazaki Y; Hirai H
    Bone Marrow Transplant; 1998 Oct; 22(8):751-4. PubMed ID: 9827971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow transplantation and nursing care].
    Ricou S
    Soins; 2008 Mar; (723):53-5. PubMed ID: 18380316
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for inherited diseases.
    O'Marcaigh AS; Cowan MJ
    Curr Opin Oncol; 1997 Mar; 9(2):126-30. PubMed ID: 9161789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs.
    Lee PW; Cina RA; Randolph MA; Goodrich J; Rowland H; Arellano R; Kim HB; Sachs DH; Huang CA
    Exp Hematol; 2005 Mar; 33(3):371-9. PubMed ID: 15730861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematologic resuscitation. II. Correction of severe leukocyte and immune globulin disorders. The bone marrow graft].
    Schwarzenberg L; Cattan A; Schneider M; Schlumberger JR; Amiel JL; Mathé G
    Presse Med (1893); 1966 Apr; 74(21):1061-5. PubMed ID: 5325498
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation.
    Aranha FJ; Vigorito AC; De Sousa CA; Oliveira GB; Zulli R; Lorand-Metze I
    Haematologica; 2002 Feb; 87(2):219-20. PubMed ID: 11836174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation.
    Curr Opin Oncol; 1997 Mar; 9(2):B41-7. PubMed ID: 9161802
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transplantation of allogeneic peripheral hematopoietic progenitor cells instead of bone marrow].
    Gratwohl A; Tichelli A; Bargetzi M; Jeannet M; Nissen C; Speck B
    Schweiz Med Wochenschr; 1996 Mar; 126(9):357-61. PubMed ID: 8701253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic graft-versus-host reaction following bone marrow transplantation].
    Ippen H; Nagel G
    Hautarzt; 1984 Apr; 35(4):182-7. PubMed ID: 6373672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation.
    Lauer BA; Githens JH; Hayward AR; Conrad PD; Yanagihara RT; Tubergen DG
    Pediatrics; 1982 Jul; 70(1):43-7. PubMed ID: 6806770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
    Davies SM; Weisdorf DJ; Haake RJ; Kersey JH; McGlave PB; Ramsay NK; Blazar BR
    Bone Marrow Transplant; 1994 Jul; 14(1):73-7. PubMed ID: 7951123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.